REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 88 filers reported holding REVANCE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,629,000 | +27.3% | 78,719 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $1,280,000 | +20.2% | 78,950 | +0.8% | 0.00% | +100.0% |
| Q2 2016 | $1,065,000 | -6.4% | 78,313 | +20.2% | 0.00% | 0.0% |
| Q1 2016 | $1,138,000 | -47.8% | 65,170 | +2.2% | 0.00% | -66.7% |
| Q4 2015 | $2,179,000 | +32.5% | 63,776 | +15.3% | 0.00% | +50.0% |
| Q3 2015 | $1,645,000 | -7.6% | 55,292 | -0.7% | 0.00% | 0.0% |
| Q2 2015 | $1,780,000 | +219.0% | 55,668 | +106.6% | 0.00% | +100.0% |
| Q1 2015 | $558,000 | +24.0% | 26,941 | +1.5% | 0.00% | 0.0% |
| Q4 2014 | $450,000 | -11.6% | 26,536 | +0.8% | 0.00% | 0.0% |
| Q3 2014 | $509,000 | -30.3% | 26,314 | +22.5% | 0.00% | 0.0% |
| Q2 2014 | $730,000 | +20.7% | 21,483 | +11.9% | 0.00% | 0.0% |
| Q1 2014 | $605,000 | – | 19,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |